GlassScriptPhysician profile
Raymond Greaser
NPI 1891795688
$9,013.40
in general payments reported to CMS, 2019-2025
13 companies · $3,148 in 2025
The $3,148 reported for 2025 was more than what 86% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,789 · 2020: $1,233 · 2022: $278 · 2024: $566 · 2025: $3,148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,140 · Travel and Lodging: $1,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,140.20 |
| Travel and Lodging | $1,573.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,708.03 | 2019-2025 | Eterna |
| Medtronic USA, INC. | $2,032.45 | 2019 | |
| Medtronic, INC. | $1,709.32 | 2024-2025 | Inceptiv, Vectris Surescan, Intellis Adaptivestim |
| Si-Bone, INC. | $1,277.62 | 2020-2025 | |
| Stryker Corporation | $671.49 | 2025 | Mild Device Kit, Spinejack |
| Boston Scientific Corporation | $286.83 | 2020-2022 | |
| Flowonix Medical Incorporated | $195.86 | 2019 | |
| Tersera Therapeutics LLC | $59.07 | 2025 | Prialt |
| Scilex Pharmaceuticals INC. | $15.84 | 2019 | |
| Avanos Medical | $15.43 | 2022 | |
| Arbor Pharmaceuticals, INC. | $15.35 | 2020 | |
| Pfizer INC. | $14.28 | 2020 | |
| Stimwave Technologies Incorporated | $11.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Greaser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.